Privia Health Group, Inc.
Company & revenue
About Privia Health Group, Inc.
Who they are
Privia Health Group, Inc. functions as a national entity focused on empowering physicians throughout the United States. It partners with medical groups, health plans, and health systems, with the primary objective of optimizing physician practices, enhancing patient experiences, and appropriately compensating clinicians for care delivered both virtually and in person. To achieve this, Privia offers a comprehensive suite of services.
Detailed revenue, brand and relationship research has not yet been completed for PRVA.
Wall Street Score
Overall investment score · Quality, value, risk and opportunity
41
Weak
View category scores →
Company Quality
How good is the actual business—regardless of today’s stock price?
56
Fair
Financial Strength
41
Business Quality / Moat
89
Management
40
Growth Quality
62
Risk / Durability
45
Uses financial strength, moat, management, growth quality and durability. It excludes share price, P/E, market cap, intrinsic value and margin of safety.
Opportunity
Opportunity Score · How does the current price compare with estimated value?
30
Avoid
Based on current valuation, company quality, recent trends, and available market signals.
View score details →
Model Outlook
12-month model · What does the model think happens next?
44/100
Building Historical Record
Model Score 44/100 — estimates relative performance potential, distinct from WallStreetScore (company quality).
Probability unavailable — the model has not produced a calibrated probability yet.
Click for full breakdown →
WSS View
The quick read
WSS currently sees meaningful weaknesses in the company-strength profile.
At today’s price, the WSS valuation framework currently reads as less attractive based on the available valuation and market data.
The model outlook is currently cautious.
- •Asset quality scores strongly
- •Valuation is a weaker part of the current profile
- •Revenue fundamentals are weak
- •Debt / balance-sheet profile needs attention
Company-specific research
Questions worth answering for PRVA
These questions are generated from this company's current financial and score data so the page adds context instead of treating the headline score as a stand-alone conclusion.
- •Can PRVA maintain its current revenue growth rate and improve the amount of that revenue that turns into earnings and cash?
- •Is PRVA's positive free cash flow repeatable, or is the current level being helped by temporary working-capital or spending changes?
- •How is PRVA likely to use its cash advantage: reinvestment, acquisitions, debt reduction, dividends or buybacks?
- •What future growth or profitability would be needed to justify PRVA's current valuation?
- •What does the current fundamental change risk warning mean for the reliability or interpretation of PRVA's score?
Essential Investment Snapshot
Wall Street Score
41
Opportunity Score
30
Market Cap
$2.56B
P/E Ratio
88.7
EPS
$0.22
52-Week High
$28.82
52-Week Low
$18.77
Beta
0.88
Intrinsic Value
$8.66
Analyst Target
$26.00
Shares Outstanding
128.9M
Total Revenue
$2.36B
Total Debt
$8.73B
Dividend
No current dividend
Liquidation Value / Share
$6502.23
Momentum & Volatility Signals
Two different market-behavior signals. Momentum measures direction and trend strength. Volatility measures how large and unstable the price moves are, regardless of direction.
Weakening momentum
Low movement
A high momentum score means price has been trending upward with confirming short- and medium-term strength. A low score means downward or weakening momentum.
A high volatility score means larger, less stable price swings. It can happen while a stock is rising or falling, so high volatility is not automatically bullish or bearish.
Important: the volatility score above is based on realized price volatility. Implied volatility (IV) comes from options prices and represents the market's expected future movement. Wall Street Score will keep IV separate and will only display it when a verified options-chain feed is available.
Community Sentiment
0 active · 0 total callsNo personal call yet on PRVA.
What the Bulls Say
- +Growth opportunities may come from revenue expansion, margin improvement, new products, market-share gains, and stronger cash flow.
- +Product opportunity: Privia Health Group, Inc. functions as a national entity focused on empowering physicians throughout the United States. It partners with medical groups, health plans, and health systems, with the primary objective of optimizing physician practices, enhancing patient experiences, and appropriately compensating clinicians for care delivered both virtually and in person. To achieve this, Privia offers a comprehensive suite of services. These include technology and population health tools designed t.
- +Positive free cash flow may provide capacity to invest in growth.
What the Bears Say
- −Key risks may include competition, margin pressure, debt levels, valuation risk, and changes in demand within the Medical - Healthcare Information Services industry.
Bull and bear cases summarize disclosed catalysts, growth opportunities and risks; they are not buy or sell recommendations.
Create a free account to make a call.
Scores
Click any score for full breakdownWas this stock page easy to understand?
One click helps us improve the research experience. This is not tied to an investment decision.
Score Changes
2 historical score records availablePrevious Score
40
Jul 24, 2026
Change
+0.8
points
Current Score
41
Oct 1, 2026
Category Changes
PRVA increased 0.8 points because Revenue improved by 8 points, Asset improved by 25.9 points, Capital improved by 2 points.
Positive Contributors
- + Revenue improved by 8 points
- + Asset improved by 25.9 points
- + Capital improved by 2 points
Negative Contributors
- − Management declined by 25.9 points
Projected Score
Projected Score
44
Projected Change
+3.0%
Preliminary comparable-period financial changes suggest improvement of approximately 3.0 points. This is a projected estimate, not the official WallStreetScore.
Price vs. Value
OvervaluedCurrent Price
$20.30
Intrinsic Value
$8.66
Difference
+$11.64
+134.4% vs IV
Margin of Safety
-134.4%
Related Companies
Medical - Healthcare Information ServicesNews
Bank of New York Mellon Corp Purchases Shares of 2,892,536 Privia Health Group, Inc. $PRVA
Deutsche Bank AG Makes New $6.02 Million Investment in Privia Health Group, Inc. $PRVA
BlackRock Inc. Makes New Investment in Privia Health Group, Inc. $PRVA
Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of Directors
Related Stock Research
Continue researching this company with related Wall Street Score rankings and investing guides.
Score Alerts
Premium unlocks alerts when a score rises, falls, or reaches your target price.
Start 7-Day Free TrialPortfolio Score
Premium unlocks portfolio scoring, strongest and weakest holdings, and overall margin of safety.
Start 7-Day Free Trial